Another Biotech Bites the Dust as Cambridge's Raze Shuts Down Post author:Sam Post published:December 13, 2017 Post category:BioPharma Reportedly, Raze Therapeutics, a biotech launched in 2014, has closed its doors. Source: BioSpace You Might Also Like Valeant Board Of Directors Issues Statement On s Cooperation With Senate Committee On Aging April 11, 2016 22nd Century Group, Inc. Now Free Of Restrictive License Agreement With September 24, 2017 Ag Biotech Company Announces $24MM C Round Financing July 9, 2017
Valeant Board Of Directors Issues Statement On s Cooperation With Senate Committee On Aging April 11, 2016
